Criteria for deciding cost-effectiveness for expensive new anti-cancer agents.

Simple item page
dc.contributor.authorSarin, Rajiven_US
dc.date.accessioned2008-01-18en_US
dc.date.accessioned2009-06-01T16:27:54Z
dc.date.available2008-01-18en_US
dc.date.available2009-06-01T16:27:54Z
dc.date.issued2008-01-18en_US
dc.identifier.citationSarin R. Criteria for deciding cost-effectiveness for expensive new anti-cancer agents. Journal of Cancer Research and Therapeutics. 2008 Jan-Mar; 4(1): 1-2en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/111571
dc.language.isoengen_US
dc.source.urihttps://www.cancerjournal.neten_US
dc.subject.meshAntineoplastic Agents --economicsen_US
dc.subject.meshCost-Benefit Analysisen_US
dc.subject.meshHumansen_US
dc.subject.meshNeoplasms --drug therapyen_US
dc.titleCriteria for deciding cost-effectiveness for expensive new anti-cancer agents.en_US
dc.typeEditorialen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of Cancer Research and Therapeutics